|
US6555692B1
(en)
*
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
|
SE9601318D0
(sv)
*
|
1996-04-04 |
1996-04-04 |
Pharmacia Biosensor Ab |
Method for nucleic acid analysis
|
|
US6251591B1
(en)
*
|
1997-02-27 |
2001-06-26 |
Lorne Park Research, Inc. |
Quantitative method for detecting nucleotide concentration
|
|
US6046004A
(en)
*
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
|
WO1999022018A2
(en)
*
|
1997-10-27 |
1999-05-06 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to pna molecular beacons
|
|
US6361942B1
(en)
*
|
1998-03-24 |
2002-03-26 |
Boston Probes, Inc. |
Method, kits and compositions pertaining to detection complexes
|
|
US6858390B2
(en)
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
|
US6403313B1
(en)
*
|
1999-12-21 |
2002-06-11 |
Ingeneus Corporation |
Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators
|
|
US6420115B1
(en)
|
1999-12-21 |
2002-07-16 |
Ingeneus Corporation |
Cation mediated triplex hybridization assay
|
|
US6656692B2
(en)
*
|
1999-12-21 |
2003-12-02 |
Ingeneus Corporation |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
|
US6294333B1
(en)
*
|
1998-12-31 |
2001-09-25 |
Ingeneus Corp. |
Fluorescent intensity assay for protein or peptide binding to nucleic acids
|
|
JP2003530817A
(ja)
|
1999-06-01 |
2003-10-21 |
ベイラー カレッジ オブ メディスン |
聴覚障害、変形性関節症および細胞の異常増殖に関するatonal関連配列の治療用途のための組成物および方法
|
|
NZ528967A
(en)
|
1999-06-22 |
2005-03-24 |
Invitrogen Corp |
Improved primers and methods for the amplification and discrimination of nucleic acids
|
|
US6645733B1
(en)
|
1999-06-25 |
2003-11-11 |
Ingeneus Corporation |
Fluorescent intensity method for assaying binding between proteins or peptides
|
|
US6830902B1
(en)
|
1999-07-02 |
2004-12-14 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
|
US7052844B2
(en)
*
|
1999-12-21 |
2006-05-30 |
Ingeneus, Inc. |
Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
|
|
US6911536B1
(en)
|
1999-12-21 |
2005-06-28 |
Ingeneus Corporation |
Triplex and quadruplex catalytic hybridization
|
|
US6927027B2
(en)
|
1999-12-21 |
2005-08-09 |
Ingeneus Corporation |
Nucleic acid multiplex formation
|
|
US20030181412A1
(en)
*
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
|
US7309569B2
(en)
*
|
1999-12-21 |
2007-12-18 |
Ingeneus, Inc. |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
|
US6924108B2
(en)
*
|
1999-12-21 |
2005-08-02 |
Ingeneus Corporation |
Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
|
|
US7220541B2
(en)
|
2000-01-24 |
2007-05-22 |
Ingeneus, Inc. |
Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
|
|
US6265170B1
(en)
|
2000-01-24 |
2001-07-24 |
Ingeneus Corporation |
Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
|
|
US20030170659A1
(en)
*
|
2000-01-24 |
2003-09-11 |
Ingeneus Corporation |
Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding
|
|
US6613524B1
(en)
|
2000-01-24 |
2003-09-02 |
Ingeneus Corporation |
Amperometric affinity assay and electrically stimulated complexes of nucleic acids
|
|
US6982147B2
(en)
*
|
2000-01-24 |
2006-01-03 |
Ingeneus Corporation |
Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions
|
|
DE60141205D1
(de)
*
|
2000-04-03 |
2010-03-18 |
Cytyc Corp |
Nachweis und typisierung des papillomavirus mittels pna-sonden
|
|
US6936443B2
(en)
*
|
2000-04-03 |
2005-08-30 |
Cytyc Corporation |
Detection and typing of human papillomavirus using PNA probes
|
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
|
US20030165859A1
(en)
*
|
2001-10-23 |
2003-09-04 |
Invitrogen Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
|
DE10155031A1
(de)
*
|
2001-11-09 |
2003-05-28 |
Friz Biochem Gmbh |
Fluoreszenz-Quenchen zur Detektion von Ligat-Ligand Assoziationsereignissen in elektrischen Feldern
|
|
EP2128248B2
(en)
|
2002-02-01 |
2017-01-11 |
Life Technologies Corporation |
Oligonucleotide compositions with enhanced efficiency
|
|
EP1572902B1
(en)
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
US6818420B2
(en)
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
|
CN101912421A
(zh)
|
2002-08-12 |
2010-12-15 |
杰能斯有限公司 |
涉及痘病毒和癌的方法及组合物
|
|
US20040180345A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Ingeneus Corporation |
Pre-incubation method to improve signal/noise ratio of nucleic acid assays
|
|
DE602005021525D1
(de)
|
2004-09-14 |
2010-07-08 |
Univ Colorado |
R behandlung mit bucindolol
|
|
SG155995A1
(en)
*
|
2004-09-24 |
2009-10-29 |
Ingeneus Inc |
Genomic assay
|
|
JP2006254784A
(ja)
*
|
2005-03-17 |
2006-09-28 |
Institute Of Physical & Chemical Research |
プライマーダイマーからの非特異的増幅を減少させる方法
|
|
US9180149B2
(en)
|
2005-09-07 |
2015-11-10 |
Sillajen Biotherapeutics, Inc. |
Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
DE602005003374T2
(de)
*
|
2005-10-17 |
2008-09-11 |
Pls-Design Gmbh |
Verfahren zur Bestimmung einer unbekannten PNS Seqenz und seine Verwendungen
|
|
EP2064229B1
(en)
|
2006-09-15 |
2015-08-12 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
|
WO2010111656A2
(en)
*
|
2009-03-27 |
2010-09-30 |
Life Technologies Corporation |
Systems and methods for assessing images
|
|
EP2449104B1
(en)
|
2009-06-29 |
2014-06-04 |
Luminex Corporation |
Chimeric primers with hairpin conformations and methods of using same
|
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
|
AU2010291901C1
(en)
|
2009-09-14 |
2016-03-03 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus combination cancer therapy
|
|
CN102858959B
(zh)
|
2009-12-10 |
2016-02-24 |
渥太华医院研究院 |
溶瘤弹状病毒
|
|
CA2822747A1
(en)
|
2009-12-23 |
2011-06-30 |
Arca Biopharma, Inc. |
Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
|
|
AU2012204467B2
(en)
|
2011-01-04 |
2016-08-18 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
|
EP2681566A2
(en)
|
2011-02-28 |
2014-01-08 |
University of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
|
EP2683835B1
(en)
|
2011-03-08 |
2017-01-11 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
|
EP2718427B1
(en)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Compositions for glioblastoma treatment
|
|
RU2483049C2
(ru)
*
|
2011-07-21 |
2013-05-27 |
Открытое акционерное общество "Научно-исследовательский институт полимерных материалов" |
Способ изготовления партии многошашечных зарядов твердого ракетного топлива
|
|
WO2013036799A2
(en)
|
2011-09-09 |
2013-03-14 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving nkg2d inhibitors and cancer
|
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
|
EP2958994B1
(en)
|
2013-02-21 |
2019-05-29 |
Turnstone Limited Partnership |
Vaccine composition
|
|
US20150098940A1
(en)
|
2013-10-03 |
2015-04-09 |
Oklahoma Medical Research Foundation |
Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
|
|
CA2969145A1
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
|
EP3350343B1
(en)
|
2015-09-16 |
2020-04-22 |
Petaomics, Inc. |
Methods and compositions for genomic target enrichment and selective dna sequencing
|
|
US12492423B2
(en)
|
2015-09-16 |
2025-12-09 |
PetaOmics, Inc. |
Methods and compositions for genomic target enrichment and selective DNA sequencing
|
|
CA3049778C
(en)
|
2017-01-26 |
2024-06-18 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
|
US12140592B2
(en)
|
2017-06-16 |
2024-11-12 |
Oklahoma Medical Research Foundation |
Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
|
|
US20210349088A1
(en)
|
2018-10-18 |
2021-11-11 |
Oklahoma Medical Research Foundation |
Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
|
|
US12510539B2
(en)
|
2018-10-18 |
2025-12-30 |
Progentec Diagnostics, Inc. |
Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
|
|
AU2019371161A1
(en)
|
2018-10-31 |
2021-06-17 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Biomarkers and methods of use for radiation-induced lung injury
|
|
US20220296622A1
(en)
|
2019-09-16 |
2022-09-22 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of swi-snf mutant tumors
|